Succinyl Liposome is a carboxyl-containing liposome that can be activated by EDC (1-ethyl-3-[3-dimethylaminopropyl]carbodiimide) and combined with sulfo-NHS (N-hydroxysulfosuccinate imides) to generate more stable and soluble species-reactive intermediates. This intermediate can be covalently attached to an amine group on a protein, peptide or antibody by substituting an amine for the sulfo-NHS group. To this end, CD Bioparticles developed Succinyl Liposome for binding to peptides, antibodies and other NHS-containing biomolecules.
CD Bioparticles manufactures and supplies succinyl liposomes for the research of drug delivery. Contact us to find out how the succinyl liposomes can help your work.
|Product Name||Catalog||Lipid composition||Liposome Size||Price|
|Clipos™ Succinyl Liposomes, Non PEGylated||CDEIMS-1524||L-a-PC/Cholesterol/1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-(succinyl) (69/30/1 molar ratio)||100 nm||INQUIRY|
|Clipos™ Succinyl Liposomes, PEGylated||CDEIMS-1526||HSPC/Cholesterol/DSPE-PEG(2000)/DSPE-PEG(2000)-Succinyl (57/38/4/1 molar ratio)||100 nm||INQUIRY|
Drug Delivery Nanoparticles Formulation
Bioparticles Analysis and Characterization
Bioactive Particles & Fillers Production
Functional Biomedical Coatings